Science for longer happier life
Enriched Collagen With Natural Matrix
Biocompatible And Biodegradable
SynDerm
SynDerm, is Medical Technology company based on tissue engineering strategies to promote skin ulcers regeneration
SynِDerm: is an academic based tissue engineering company to reconstruct skin and mucosa.
Dermobor: is the brand name of an advanced wound care product of SynDerm.
Mission: to develop effective and practical acellular xenografts for mucosa and skin regeneration as temporary wound dresser in animal and human.
Vision: to be a leader in the acellular skin xenograft industry in the global market to treat and regenerate animals and human dermal and mucosal tissues.
Dr.Leila Roshangar
CEO/ Founder:
Professor of Anatomical Sciences, Post doc in Regenerative Medicine, Director of stem cell research center, 20 years of academic career.
Role: CEO
Tissue Engineered Skin
Based on the Tissue Engineered Skin Substitutes industrial chain, this report mainly elaborates the definition, types, Application and major players of Tissue Engineered Skin Substitutes market in
details. Deep analysis about market status (2016-2021E), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2021E-2026F), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to downstream buyers of this industry will be analyzed
scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Tissue Engineered Skin Substitutes market.
Tissue engineering which is applied in regenerative medicine has three basic components: cells, scaffolds and growth factors. This multidisciplinary field can regulate cell behaviours in different conditions using scaffolds and growth factors.
Scaffolds can form an integral part of tissue engineering as an extracellular matrix for cell growth and proliferation. Decellularized biological scaffolds have advantages over synthetic scaffolds, including being natural, easily available, and economical. They can be extracted from various tissues including the bladder, small intestine, liver and tracheal tissues.
Our results in SynDerm, indicated that the ultrastructure of the scaffold is maintained after the decellularization process and despite the low thickness of the scaffold, it had suitable mechanical resistance and shows acceptable stability. We hold that the scaffold could have the ability to expedite the repair and regeneration of wound management such as burns as a suitable skin dress.
